基于利钠肽的美国2型糖尿病患者心力衰竭前期筛查 - Suppr | 超能文献

Natriuretic Peptide-Based Screening for Pre-Heart Failure in Patients With Type 2 Diabetes Across the United States.

作者信息

Cunningham Jonathan W, Claggett Brian L, Solomon Scott D, Vaduganathan Muthiah

出版信息

JACC Heart Fail. 2023 Jun;11(6):724-726. doi: 10.1016/j.jchf.2023.01.012. Epub 2023 Mar 1.

DOI:10.1016/j.jchf.2023.01.012

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Natriuretic Peptide-Based Screening for Pre-Heart Failure in Patients With Type 2 Diabetes Across the United States.基于利钠肽的美国2型糖尿病患者心力衰竭前期筛查

JACC Heart Fail. 2023 Jun;11(6):724-726. doi: 10.1016/j.jchf.2023.01.012. Epub 2023 Mar 1.

2

Natriuretic Peptide-Based Screening to Identify Stage B Heart Failure in People With Type 1 Diabetes.基于利钠肽的筛查以识别1型糖尿病患者的B期心力衰竭

J Am Heart Assoc. 2024 Feb 6;13(3):e033448. doi: 10.1161/JAHA.123.033448. Epub 2024 Jan 31.

3

Risk Estimates of Imminent Cardiovascular Death and Heart Failure Hospitalization Are Improved Using Serial Natriuretic Peptide Measurements in Patients With Coronary Artery Disease and Type 2 Diabetes.在患有冠状动脉疾病和 2 型糖尿病的患者中，使用连续的利钠肽测量可改善即将发生的心血管死亡和心力衰竭住院的风险估计。

J Am Heart Assoc. 2022 Apr 19;11(8):e021327. doi: 10.1161/JAHA.121.021327. Epub 2022 Apr 6.

4

Does canagliflozin decrease natriuretic peptide levels in patients with diabetes and heart failure?卡格列净能否降低糖尿病合并心力衰竭患者的利钠肽水平？

Cardiol J. 2022;29(1):166-169. doi: 10.5603/CJ.a2021.0169. Epub 2021 Dec 21.

5

The Jury Is Still Out on A-Type Natriuretic Peptide Deficiency Relative to B-Type Natriuretic Peptides.关于相对于B型利钠肽的A型利钠肽缺乏症，尚无定论。

JACC Heart Fail. 2024 Mar;12(3):475-478. doi: 10.1016/j.jchf.2023.11.012. Epub 2024 Jan 10.

6

Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes.实验室和临床中的新兴生物标志物：一种诊断糖尿病心力衰竭的新方法。

J Diabetes Sci Technol. 2024 May;18(3):733-740. doi: 10.1177/19322968241227898. Epub 2024 Jan 31.

7

Natriuretic Peptide Guidance for Post-Myocardial Infarction Care: An Opportunity to Prevent Heart Failure Progression.利钠肽指导心肌梗死后护理：预防心力衰竭进展的契机

Circ Heart Fail. 2023 May;16(5):e010540. doi: 10.1161/CIRCHEARTFAILURE.123.010540. Epub 2023 May 1.

8

Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice.利钠肽测量是临床试验和临床实践中解决问题的关键。

JACC Heart Fail. 2020 Sep;8(9):782-783. doi: 10.1016/j.jchf.2020.06.011.

9

Reply: Natriuretic Peptide Measurement Is Key to a Solution in the Clinical Trial and Clinical Practice.回复：利钠肽检测是临床试验和临床实践中解决问题的关键。

JACC Heart Fail. 2020 Sep;8(9):783-784. doi: 10.1016/j.jchf.2020.07.001.

10

So-far overlooked HFpEF patients with normal natriuretic peptide level need more evidence.迄今为止被忽视的利钠肽水平正常的射血分数保留的心力衰竭（HFpEF）患者需要更多证据。

ESC Heart Fail. 2022 Oct;9(5):3659-3660. doi: 10.1002/ehf2.14047. Epub 2022 Jun 21.

引用本文的文献

1

Mechanisms of diabetic cardiomyopathy: Focus on inflammation.糖尿病性心肌病的发病机制：聚焦于炎症

Diabetes Obes Metab. 2025 May;27(5):2326-2338. doi: 10.1111/dom.16242. Epub 2025 Feb 10.

2

Myocardial Abnormalities Across the AHA/ACC Stages of Heart Failure in Patients With Diabetes.糖尿病患者中，美国心脏协会/美国心脏病学会心力衰竭各阶段的心肌异常情况

JACC Asia. 2024 Oct 22;4(12):940-952. doi: 10.1016/j.jacasi.2024.08.016. eCollection 2024 Dec.

3

Natriuretic Peptide-Based Screening to Identify Stage B Heart Failure in People With Type 1 Diabetes.基于利钠肽的筛查以识别1型糖尿病患者的B期心力衰竭

J Am Heart Assoc. 2024 Feb 6;13(3):e033448. doi: 10.1161/JAHA.123.033448. Epub 2024 Jan 31.